26 August 2022
: Case report
An 81-Year-Old Man with a 6-Year History of Chronic Lymphocytic Leukemia Presenting with Disease Flare Following Ibrutinib Discontinuation
Unusual clinical course, Challenging differential diagnosis, Unusual or unexpected effect of treatment
Stefano Pozzi1EF*, Leonardo Potenza12AE, Davide Giusti
DOI: 10.12659/AJCR.935941
Am J Case Rep 2022; 23:e935941
Figure 2. Computed tomography (CT) images of the abdomen. (A) Axial image showing abdominal lymphadenopathy (white arrow) after 6 months of ibrutinib treatment (in May 2019). (B) Axial CT image showing marked lymphadenopathy enlargement after ibrutinib suspension (white arrow).